Investors are bracing for the start of Donald Trump’s second term, with the US president-elect due to be sworn in on Monday.
Trump has warned that a wave of executive orders would be signed upon him returning to the White House. He and top aide Stephen Miller have said that the total could be close to 100 executive actions in the early days of his second presidency.
The orders are expected to focus on topics ranging from immigration policies to energy, as well as trade tariffs.
More supportive policies for cryptocurrencies are also expected to form part of Trump’s agenda. In fact, both the president-elect and his wife, Melania Trump, launched their own meme coins over the weekend.
Shares in Trump Media were on the rise last week, ahead of the inauguration, though US markets are closed on Monday for Martin Luther King Day.
Read more: FTSE 100 LIVE: London stocks rise as Donald Trump prepares to take office
Jim Reid, market strategist at Deutsche Bank (DBK.DE), said: “The common perception in politics is that in his first term Mr Trump was less prepared for office than he is this time round in terms of personnel and infrastructure so under this view you can expect him to hit the ground running with immediate policy moves.”
Reid highlighted that Trump issued 55 executive orders in his first year in office back in 2017, and 220 in total during his four year term.
“For modern day comparison, Reagan issued 381 in eight years, GHW Bush 166 in four years, Clinton 364 in eight years, GW Bush 291 in eight years, Obama 276 in eight years and Biden 160 in four.” he said. “So in the last 45 years Trump has made more use of his executive power than any other president.”
Shares in Intel surged 9% on Friday, on the back of a report that the company could be an acquisition target.
SemiAccurate reported on Friday that a mystery company is trying to acquire the company as a whole. A spokesperson for Intel declined to comment on the report.
The reports come ahead of Intel’s fourth quarter results, which are due to be released next week, on Thursday 30 January.
Read more: Pound, gold and oil prices in focus: commodity and currency check, 20 January
Intel’s shares popped in October, after the chipmaker guided to revenue of between $13.3bn (£10.9bn) and $14.3bn for the fourth quarter, versus Wall Street expectations of $13.6bn.
However, shares are still down 54% over the past year, with the company having faced a series of struggles.
This prompted Pat Gelsinger, who retired as Intel CEO last month, to announce in August “significant actions” to reduce costs. He said the firm planned to deliver $10bn in cost savings in 2025, which included reducing the company’s head count by around 15,000 roles.
Despite nervousness over China being in line for the harshest tariff policies once Trump returns to the White House, Hong Kong-listed stocks rose in Monday’s session.
Data released Friday showed that China’s economy grew by 5% last year, which was in line with the government’s target.
Read more: Stocks that are trending today
Meanwhile, a phone call between Trump and Chinese president Xi Jinping on Friday, appeared to add investor optimism. Trump said he discussed “balancing” social media app TikTok, which is owned by China’s ByteDance, with the Chinese president.
The US Supreme Court then on Friday rejected TikTok’s appeal to overturn a ban on the social media platform. The app went dark in the US after the ban came into effect on Sunday but then was back online, after Trump intervened and pledged to issue an executive order to delay the ban.
Hong Kong’s Hang Seng index (^HSI) closed Monday’s session up 1.75%, with e-commerce giants Alibaba and JD.com (9618.HK) rising nearly 5% and 7% respectively.
Shares in pharmaceuticals firm Novo Nordisk fell on Friday and were flat on Monday morning, following the news that the US Medicare government health insurance programme was seeking to negotiate prices on 15 drugs.
This included Novo Nordisk’s GLP-1 weight-loss drugs Ozempic and Wegovy. The list also included drugs from other pharmaceuticals giants Pfizer (PFE), AstraZeneca (AZN.L, AZN) and Merck (MRK).
Stocks: Create your watchlist and portfolio
Novo Nordisk shares saw their sharpest one-day decline in the company’s history in December, following disappointing results from the latest trial of its weight-loss drug, CagriSema.
Friday’s share price fall saw Novo Nordisk be overtaken by luxury goods firm LVMH (MC.PA) as Europe’s largest company for the time since September 2023, according to a Bloomberg report.
Shares in LVMH rallied on Thursday, along with other luxury stocks, after Cartier-owner Richemont (CFR.SW) posted strong sales.
The UK’s accounting watchdog announced on Monday that it had started an investigation into an audit conducted by KPMG of Ladbrokes-owner Entain.
The Financial Reporting Council (FRC) said that the probe was regarding KPMG’s audit of Entain’s financial statements for the year ended 31 December 2022.
Read more: UK economic growth set to accelerate in 2025, IMF forecasts
However, the announcement stressed that the investigation “does not relate to any persons or entities other than the relevant statutory auditor(s) and/or statutory audit firm(s) and it would not be fair to treat any part of this announcement as constituting or evidencing an investigation into any other persons or entities.”
A KPMG UK spokesperson said: “We will cooperate fully with the FRC to conclude this matter as quickly as possible.” Entain declined to comment.
Tesla (TSLA)
Meta (META)
Vodafone Idea Limited (IDEA.NS)
BTC Digital (BTCT)
Read more:
Download the Yahoo Finance app, available for Apple and Android.